Overview
Sara Horton is an Oncologist practicing medicine in Washington, Washington, D.c..
Her clinical expertise encompasses Triple-Negative Breast Cancer and Breast Cancer.
She is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
2041 Georgia Ave NW, Washington, DC 20060
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MedStar Georgetown University Hospital
Bruce Cheson is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Cheson is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Non-Hodgkin Lymphoma. Dr. Cheson is currently accepting new patients.
MedStar Georgetown University Hospital
David Vesole is an Oncologist and a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Vesole is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Vesole is board certified in American Board Of Internal Medicine. Dr. Vesole is currently accepting new patients.
MedStar Georgetown Cancer Institute At MedStar Georgetown University Hospital
Michael Atkins is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Atkins is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, Pancreaticoduodenectomy, and Nephrectomy.
MedStar Georgetown Cancer Institute At MedStar Georgetown University Hospital
Benjamin Weinberg is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Weinberg is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Pancreaticoduodenectomy, and Vertebroplasty. Dr. Weinberg is currently accepting new patients.
Children's National Hospital
Emily Meier is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Meier is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Meier is currently accepting new patients.
Sibley Memorial Hospital
Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Levy is board certified in American Board Of Internal Medicine. Dr. Levy is currently accepting new patients.
Frequently Asked Questions about Dr. Sara Horton
How do I make an appointment with Dr. Sara Horton?
You can book an appointment with Dr. Sara Horton by calling their office at 202-865-4037. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sara Horton a top-rated expert for Triple-Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sara Horton is classified as an Experienced expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sara Horton specialize in?
While Dr. Sara Horton is a Oncology, they have specific expertise in Triple-Negative Breast Cancer, Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Sara Horton participate in research or clinical trials?
Yes. Dr. Sara Horton has published 12 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Dr. Sara Horton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Sara Horton accept my insurance?
Dr. Sara Horton accepts most major insurance plans, including CareFirst and Humana. We recommend calling the office directly at 202-865-4037 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerDr. Horton isExperienced. Learn about Breast Cancer.
- Triple-Negative Breast CancerDr. Horton isExperienced. Learn about Triple-Negative Breast Cancer.
